Milwaukee, WI - June 1, 2010 - Mortara Instrument announced today it was awarded a 3-year cardiology monitoring contract by Broadlane, Inc. to provide resting ECG, stress testing, and Holter equipment to its many facilities.
As a leading provider of cost management and supply chain solutions to the acute, post-acute, and the outpatient service markets, Broadlane represents 1,100 IDNs and hospitals, 5,000 ambulatory care and surgery centers, and 36,000 physician practices in every region of the United States.
“We are very pleased to have been selected as a cardiology provider to Broadlane,” commented Dr. Justin L. Mortara, Ph.D., CEO of Mortara Instrument. “We believe their extensive evaluation of our product offering served us well. As a result, Broadlane’s many facilities will benefit from a technologically and clinically superior product and Mortara will enjoy a significant expansion of its presence in acute-care hospitals.”
Mortara’s ELI™ electrocardiographs are used worldwide in the diagnosis of heart disease. All ELI electrocardiographs support DICOM® enabling integration of patient ECG results with other important clinical parameters. Mortara’s X-Scribe™ stress testing system utilizes Mortara’s go wireless technology™ platform, delivering important clinical advantages without any price premium, and in November 2008, NASA selected Mortara’s Holter products to travel aboard Space Shuttle Endeavor.
About Mortara Instrument, Inc.
Mortara Instrument, Inc., based in Milwaukee, WI, is distinguished in the field of non-invasive diagnostic cardiology for innovations that are the core of the company’s complete line of ECG products including electrocardiographs, stress exercise systems, Holter systems and data warehousing solutions, and cardiology monitoring systems. Mortara Instrument manufactures and distributes its ECG devices and related technology worldwide. The company’s web site is www.mortara.com.
Mortara Instrument Media Contact: Sondra Kaufman; sondra.kaufman @ mortara.com